Sutro Biopharma Inc (STRO)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$20.07-2.29%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · STRO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 45.7 | 102.5 | 62.0 | 153.7 | 67.8 | 61.9 | 42.7 | 42.7 | 38.4 |
| Total Revenues | — | — | — | — | — | — | — | — | 38.4 |
| Operating Expenses & Income | |||||||||
| R&D Expenses | 144.7 | 166.4 | 252.0 | 180.4 | 137.2 | 104.4 | 77.0 | 65.6 | 54.3 |
| Operating Income | (146.1) | (158.4) | (238.5) | (89.3) | (128.9) | (98.5) | (71.1) | (55.5) | (37.2) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 1.6 |
| Interest & Investment Income | 6.9 | 9.3 | 18.6 | 14.5 | 3.5 | 0.6 | 1.5 | 4.1 | 1.6 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | 0.0 |
| Asset Writedown | — | 1.7 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (180.7) | (191.2) | (225.1) | (88.6) | (116.7) | (105.5) | (32.0) | — | — |
| Income Tax Expense | — | (0.1) | 2.4 | 18.2 | 2.5 | 0.0 | 0.1 | 0.0 | 0.0 |
| Net Income | |||||||||
| Net Income | (180.6) | (191.1) | (227.5) | (107.0) | (119.2) | (105.5) | (32.1) | (119.2) | (35.3) |
| Per Share | |||||||||
| Basic EPS | (10.90) | (22.49) | (2.96) | (1.78) | (2.35) | (2.29) | (0.99) | — | — |
| Diluted EPS | (10.90) | (22.49) | (2.96) | (1.78) | (2.35) | (2.29) | (0.99) | — | — |
| Revenue per Share | 2.76 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 16.6 | 8.5 | 76.8 | 60.2 | 50.7 | 46.1 | 32.6 | — | — |
| Diluted Weighted Avg Shares | 16.6 | 8.5 | 76.8 | 60.2 | 50.7 | 46.1 | 32.6 | — | — |
| Supplemental | |||||||||
| EBITDA | — | (151.0) | (231.2) | (82.5) | (123.3) | (93.7) | (66.8) | (50.7) | (32.7) |
| EBIT | (146.1) | (158.4) | (238.5) | (89.3) | (128.9) | (98.5) | (71.1) | (55.5) | (37.2) |
| Effective Tax Rate | — | — | — | -20.5% | -2.1% | 0.0% | -0.3% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.